Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta …
Importance Mortality among people with opioid dependence is higher than that of the
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …
Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis
J Ma, YP Bao, RJ Wang, MF Su, MX Liu, JQ Li… - Molecular …, 2019 - nature.com
Opioid use disorder (OUD) is associated with a high risk of premature death. Medication-
assisted treatment (MAT) is the primary treatment for opioid dependence. We …
assisted treatment (MAT) is the primary treatment for opioid dependence. We …
Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder
SE Hadland, SM Bagley, J Rodean… - JAMA …, 2018 - jamanetwork.com
Importance Retention in addiction treatment is associated with reduced mortality for
individuals with opioid use disorder (OUD). Although clinical trials support use of OUD …
individuals with opioid use disorder (OUD). Although clinical trials support use of OUD …
Buprenorphine treatment for opioid use disorder: an overview
M Shulman, JM Wai, EV Nunes - CNS drugs, 2019 - Springer
Opioid use disorder affects over 26 million individuals worldwide. There are currently three
World Health Organization-recommended and US Food and Drug Administration-approved …
World Health Organization-recommended and US Food and Drug Administration-approved …
Buprenorphine pharmacology review: update on transmucosal and long-acting formulations
MA Coe, MR Lofwall, SL Walsh - Journal of addiction medicine, 2019 - journals.lww.com
Buprenorphine is an effective treatment for opioid use disorder. As a high-affinity, partial
agonist for the mu-opioid receptor, buprenorphine suppresses opioid withdrawal and …
agonist for the mu-opioid receptor, buprenorphine suppresses opioid withdrawal and …
The use of opioids in the management of chronic pain: Synopsis of the 2022 updated US Department of Veterans Affairs and US Department of Defense Clinical …
F Sandbrink, JL Murphy, M Johansson… - Annals of internal …, 2023 - acpjournals.org
Description: In May 2022, leadership within the US Department of Veterans Affairs (VA) and
US Department of Defense (DoD) approved a joint clinical practice guideline for the use of …
US Department of Defense (DoD) approved a joint clinical practice guideline for the use of …
The next stage of buprenorphine care for opioid use disorder
Buprenorphine has been used internationally for the treatment of opioid use disorder (OUD)
since the 1990s and has been available in the United States for more than a decade. Initial …
since the 1990s and has been available in the United States for more than a decade. Initial …
Impact of COVID-19 telehealth policy changes on buprenorphine treatment for opioid use disorder
Objective: The authors examined the impact of COVID-19-related policies reducing barriers
to telehealth delivery of buprenorphine treatment for opioid use disorder (OUD) on …
to telehealth delivery of buprenorphine treatment for opioid use disorder (OUD) on …
[HTML][HTML] Opioid-related deaths in Europe: strategies for a comprehensive approach to address a major public health concern
H Alho, M Dematteis, D Lembo, I Maremmani… - International Journal of …, 2020 - Elsevier
Use of illicit opioids and misuse of prescription opioids are the main causes of drug-related
deaths across the world, and the continuing rise in opioid-related mortality, especially …
deaths across the world, and the continuing rise in opioid-related mortality, especially …
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
EV Nunes, FR Levin, MP Reilly, N El-Bassel - Journal of substance abuse …, 2021 - Elsevier
The temporary loosening of regulations governing methadone and buprenorphine treatment
for opioid use disorder (OUD) in the US, instituted to prevent the spread of COVID-19, has …
for opioid use disorder (OUD) in the US, instituted to prevent the spread of COVID-19, has …